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Abstract 
In humans and other mammals, it is known that calcium and phosphate ions are secreted from 
the distal small intestine into the lumen. However, why this secretion occurs is unclear. Here, 
we show that the process leads to the formation of amorphous magnesium-substituted calcium 
phosphate nanoparticles that trap soluble macromolecules, such as bacterial peptidoglycan and 
orally-fed protein antigens, in the lumen and transport them to immune cells of the intestinal 
tissue. The macromolecule-containing nanoparticles utilize epithelial M cells to enter Peyer’s 
patches - small areas of the intestine concentrated with particle-scavenging immune cells. In 
wild type mice, intestinal immune cells containing these naturally-formed nanoparticles 
expressed the immune tolerance-associated molecule ‘programmed death-ligand 1 (PD-L1)’, 
whereas in NOD1/2 double knock-out mice, which cannot recognize peptidoglycan, PD-L1 
was undetected. Our results explain a role for constitutively formed calcium phosphate 
nanoparticles in the gut lumen and how this helps to shape intestinal immune homeostasis. 
 
 
 
 
The active secretion of calcium by the gut is often referred to as the endogenous losses but why 
this should occur is not known as it contributes little to the homeostasis of calcium- its excretion 
being mediated through urine. Phosphate ions also flux between intestinal tissue and the lumen, 
so calcium phosphate precipitation may ensue1.These precipitates have not been thoroughly 
studied although a role in sequestration of bile acids and other colonic toxins has been 
proposed1. We have previously hypothesised that this process allows micrometre sized 
particles of calcium phosphate to form, which then adsorb other luminal components and carry 
them to phagocytic cells of intestinal tissue1-3. Herein we report the actual process: we show 
that, in fact, the endogenous luminal precipitates of mineralised calcium are abundant porous 
nanoparticles that appear to incorporate soluble molecules of the gut lumen and we present 
evidence for this process regulating the expression of cell surface PD-L1 on antigen presenting 
cells (APCs) in the sub-epithelial region of Peyer’s patches. PD-L1 is a cell surface immuno-
inhibitory molecule that co-regulates T lymphocyte function and, especially, promotes immune 
tolerance. 
Endogenous nanomineral of the intestinal lumen 
Distal small intestinal contents, recovered from ileostomy patients, were air dried on plastic-
coated stubs for scanning electron microscopy (SEM). Extensive numbers of sub-micrometre 
sized particles were identified (Fig. 1a-b). Their calcium and phosphorus rich elemental 
composition was confirmed by X-ray microanalysis (XRMA) and, repeatedly, magnesium was 
also present (Fig. 1c). High magnification SEM indicated that the particles were generally 
agglomerates of smaller, nanoparticulate structures (Fig. 1b). 
Characterisation of endogenous mineral of the intestinal lumen 
To avoid drying, and to better mimic in situ dispersion, whole cross-sections of non-aqueous 
resin embedded murine distal small bowel were then studied and transmission electron 
microscopy (TEM) was used to provide greater resolution. A large quantity of relatively 
electron dense nanoparticles was similarly visible (Fig. 1d) and these were again calcium (Ca) 
and phosphorus (P) rich by analysis with concomitant detectable magnesium (Mg) (Fig. 1e and 
Supplementary Fig. 1). High power TEM imaging suggested that discrete particles were 
amorphous and porous in structure and ~100 nm (typically 75-150 nm) in diameter (Fig. 1f and 
Supplementary Fig. 1). Selected area electron diffraction confirmed the lack of crystallinity 
(Inset Fig. 1f). Although our observations imply that endogenous nanomineral particles occur 
in enormous numbers in the intestinal lumen, this enumeration exceeds current analytical 
capabilities. Median calcium concentration is 4.2 mM4, in 1L/24h of succus entericus 
(intestinal juice) of the human ileum, and a third of this calcium may precipitate5. Assuming a 
P:(Ca+Mg) molar ratio and packing density similar to octacalcium phosphate (because the 
former is variable and the latter is unknown for amorphous calcium phosphate), an average 100 
nm diameter spherical particle and an estimated 50% void volume (porosity), we calculated 
that ~ 2 × 1014 luminal nanomineral particles/day will be present. This abundant endogenous 
nanomineral of amorphous magnesium-substituted calcium phosphate (AMCP) has not been 
previously observed or characterised, probably because standard processing techniques for 
microscopy and analysis would either dissolve the mineral or force agglomeration. Careful 
non-aqueous processing, however, reveals the disperse structures. 
Gut immune cells acquire the endogenous luminal nanomineral 
Non biological particles of ~20-250 nm diameter are known to efficiently cross the epithelial 
barrier of intestinal lymphoid follicles, notably the Peyer’s patches of the small intestine, and 
may accumulate in the underlying antigen presenting cells (APCs)3. We therefore studied 
frozen sections of both human and murine Peyer’s patches by light microscopy. Modified Von 
Kossa staining for mineralised phosphate revealed large numbers of positive cells within the 
sub-epithelial dome (Supplementary Fig. 2). Fluorescent calcein staining for mineralised 
calcium confirmed these observations (Fig. 2a-b) and demonstrated lysosomal localisation of 
the nanomineral (Supplementary Movie 1). A detector for back scattered electrons fitted to the 
SEM allowed the identification of regions with high elemental contrast in the same sub-
epithelial dome area and the presence of calcium, phosphorus and magnesium were confirmed 
by X-ray microanalysis (Fig. 2c). Both human and murine tissue samples were similarly 
positive for these features. 
Phenotypic and nanomineral characterisation of sub-epithelial dome (SED) cells in 
murine and human Peyer’s patches (PP) 
Fluorescently labelled antibodies were then used to confirm an APC phenotype of these 
mineral-positive cells in murine and human Peyer’s patches. We noted that artefactual staining 
could occur for these cells, presumably through adsorption of the labelled antibody to the 
intracellular mineral. Hence, we were careful to ensure that, for phenotyping, all stains showed 
cellular distributions typical of the anticipated antigen location and not simply coincidental 
with the cellular areas rich in mineral. In addition to the nuclear stain we therefore only used 
double staining, namely calcein for the mineral plus one phenotypic marker at a time. The 
majority of human and murine calcein-positive cells were strongly positive for typical cell 
surface markers on dendritic cells residing in the Peyer’s patch sub-epithelial dome6,7, namely: 
CD11b, CD11c and HLA-DR (Fig 2d-r). A distinct sub-population was also CD68high 
consistent with a mature macrophage phenotype (Fig. 2n and r). As expected in the gut the 
peripheral monocyte marker, CD14, was absent. Thus, overall, the mineral-positive cells of the 
Peyer’s patch sub-epithelial dome were phenotypically APCs. 
Imaging with TEM and scanning transmission electron microscopy (STEM) revealed that the 
individual AMCP nanomineral structures in sub-epithelial dome APCs (Fig. 3a-b) were porous 
(Fig. 3a), and often clustered possibly due to adhesion to internal vesicle membranes as this is 
well known for nanominerals in cell lysosomes3. Moreover, the particles were of similar shape, 
electron density and amorphous appearance to their luminal counterparts but generally 
appeared smaller (e.g. Fig. 3a versus Fig. 1f) indicating, perhaps, partial intracellular 
degradation. Apparent similarities in composition by imaging were confirmed analytically for 
Ca, Mg and P content, using standardless elemental quantification of X-ray microanalysis 
spectra from similar thin sections of Peyer’s patches and luminal contents (Fig. 3c). 
EM characterisation of murine endogenous nanomineral and 3D nanotomography 
This tendency for intracellular clustering of AMCP nanomineral particles facilitated 
tomographic 3-D imaging. A large intracellular cluster was identified and imaged using high 
angle annular dark field (HAADF) STEM to enable sufficient contrast with unstained non-
aqueous-resin-embedded specimens (Fig. 3d). A tilt series was recorded and reconstructed in 
three dimensions which demonstrated particles of markedly varying sizes (Fig. 3e and 
Supplementary Movie 2), consistent with intracellular AMCP nanomineral at differing stages 
of dissolution. Taken together the data above suggested that luminally formed nanomineral 
tracks to Peyer’s patch APCs and we sought to confirm this with three specific investigations. 
The first study involved dietary manipulation of the main nanomineral elements. Systemic 
calcium and phosphate levels are tightly controlled in mammals through the large skeletal pool. 
In contrast, the secretion of calcium from the circulation and into the intestinal tract (i.e. 
endogenous losses) diminishes when animals are maintained on low calcium diets (e.g. 0.1 g 
Ca/kg diet for 3 weeks versus 5 g Ca/kg diet normally)8. Thus, quantitative changes to the 
Peyer’s patch APC nanomineral, in response to dietary calcium and phosphorus deprivation, 
would strongly indicate a lumen-to-APC pathway since systemic and intracellular levels of 
these vital elements are so carefully conserved9. We took snap frozen Peyer’s patch tissue from 
four groups of mice fed diets with varying levels of these elements for three weeks. Peyer’s 
patches of all four groups revealed abundant sub-epithelial dome cells that stained normally 
for mineralised calcium (Supplementary Fig. 3a-b). However, X-ray microanalysis with SEM 
indicated that this mineralised calcium was markedly phosphate deficient for the two groups 
of mice ingesting the low dietary calcium and phosphorus diets (< 0.3 g/kg diet for either 
element: Supplementary Fig. 3c). Moreover, mineral analysis was as expected for mice 
ingesting diets replete in calcium and phosphorus (> 3.8 g/kg diet for either element: 
Supplementary Fig. 3d). Using quantitative nuclear microscopy2 mean P:Ca ratios of 1.15 
(w/w) (Fig. 3f) were identified for nanomineral of the Peyer’s patch sub-epithelial dome from 
mice on calcium and phosphorus replete diets. However, phosphate was absent from the 
mineral of mice on the diets that were low in calcium and phosphorus (Fig. 3f). The findings 
support a lumen-to-Peyer’s patch route for the endogenous AMCP nanomineral. 
The second study considered the presence of the nanomineral in Peyer’s patches of mice that 
lacked M cells. Transport into the Peyer’s patch, of other non-biological particles in the size 
range of the endogenous nanomineral, is a well described phenomenon and is chiefly mediated 
by specialist epithelial M cells3,10. We therefore compared the relative abundance of Peyer’s 
patch nanomineral by confocal microscopy in villin-cre+ RANKFL/FL mice where RANKL-
dependent intestinal M cell differentiation is prevented by conditional deletion of RANK in the 
intestinal epithelium11. In these mice M cells were absent from the follicle-associated 
epithelium overlying the Peyer’s patches (Fig. 4a) and calcein-stained nanomineral was faint 
and a rare occurrence (Fig. 4b-c). In contrast, in matched control mice with functional RANKL-
RANK signalling (i.e. RANKFL/FL mice) M cells were abundant (Fig. 4a) and calcein staining 
was normal (Fig. 4b-c). 
AMCP nanomineral uptake from the gut lumen into Peyer’s patches is substantially 
impeded in the absence of M cells in the follicle associated epithelium 
Finally, we determined the AMCP nanomineral status of murine lymphoid structures from the 
large intestine. Forming a blind end tract off the caecum is the appendix, where luminal 
contents may reside for long periods and there is also a very large area of caecal patch. 
However, hyper-exposure of caecal patch immune cells to luminal contents is probably averted 
through regulation of M cell maturation12: as such the Peyer’s patch and the caecal patch are 
very similar in terms of developmental processes as well as immunological structure and 
function13. Indeed, we confirmed that, just as for the Peyer’s patch, calcein-detectable mineral 
was also observed in caecal patch sub-epithelial immune cells (Supplementary Fig. 4). In 
contrast, the colon appears to have little capacity for particle uptake14. Consistent with this, we 
found no evidence for calcein-detectable mineral in lymphoid follicles of the colon although 
often it was detected above the apical surface of the epithelium of regular mucosa and lymphoid 
structures (Supplementary Fig. 4), perhaps due to retention in the thick adherent mucus layer 
of the colon14. 
Collectively these data indicate that the endogenous intestinal AMCP nanomineral forms in the 
lumen and enters APCs of intestinal immune-inductive sites, namely the caecal and Peyer’s 
patches, predominantly via epithelial M cells. 
The endogenous nanomineral transports luminal macromolecules 
The abundant homogenous formation of porous calcium phosphate nanomineral in the 
intestinal lumen, and its marked transport across M cells into lymphoid patch APCs, led us to 
question function. Calcium phosphates excel at trapping and carrying organic material into 
cells15. Indeed the nanomineral described here is amorphous, which contrasts with other forms 
of calcium phosphate in biological systems such as octacalcium pentophosphate and biological 
apatite16, and this could facilitate its intracellular dissolution enabling the release of trapped 
organic material. In other words, a constitutive ‘cargo ship’ function for the endogenous 
intestinal nanomineral was considered whereby soluble, luminal organic macromolecules 
could be encapsulated and then transported to gut APCs. 
A number of studies have confirmed the existence of discrete pathways for handling 
exogenously-derived cargo of differing origin at the subcellular level following the seminal 
work of Blander and Medzhitov17,18. Particulate and soluble molecules are not anticipated to 
show co-incidental intracellular fluorescent signals unless their uptake is as a single 
conjugate19-21. Therefore, in the absence of in vivo imaging techniques that could track cargo-
loading of single nanoparticles, and then show their transport from the intestinal lumen to 
Peyer’s patch cells, we considered the intracellular co-incidence of the AMCP nanomineral 
with luminally-derived molecules in sub-epithelial APCs. 
We fed BALB/c mice, maintained on a conventional diet or a calcium and phosphorus deplete 
diet, with Texas Red®-labelled ovalbumin or unlabelled ovalbumin, respectively. After 4 
hours, the protein detected in Peyer’s patches of mice on a conventional laboratory diet was 
almost solely compartmentalised within the AMCP nanomineral-positive APCs of the sub-
epithelial dome (Fig. 5a-e). Since it remained possible that ovalbumin and the fluorochrome 
were cleaved during digestion, only the latter being associated with the nanomineral, we also 
directly stained the Peyer’s patch sections for ovalbumin. Clear colocalisation was still 
observed, using the Huygens maximum least expected deconvolution algorithm to optimise 
resolution (Fig. 5f). Additionally, close but separated signals for intracellular calcein (AMCP 
nanomineral) and protein were observed (Fig. 5f): this should be expected if the nanomineral 
dissolves intra-lysosomally unmasking, and then releasing, its cargo. Similar findings were 
observed for mice fed ovalbumin on the calcium and phosphate deplete diet (Fig. 5g-k) even 
though, under these conditions, the nanomineral was calcium-rich but no longer a calcium 
phosphate (Supplementary Fig. 3c and Fig. 3f). Thus, endogenously formed nanoparticles of 
mineralised calcium appear to trap protein antigen in the gut lumen and chaperone it to Peyer’s 
patch APCs. 
Endogenous nanomineral is co-localised with luminal peptidoglycan and dietary antigen 
in Peyer’s patch (PP) APC 
Microbial associated molecular patterns (MAMPs), such as peptidoglycan, are present 
ubiquitously in the lumen of the distal gastrointestinal tract, including the ileum, due to 
turnover of the commensal microbiota. Peptidoglycan has been identified in human and rodent 
gut mucosa by the monoclonal antibody 2E922, which recognises only degraded/free 
peptidoglycan and not that present in whole bacteria23. Here, using 2E9 antibody, we showed 
that, just as for dietary-derived ovalbumin, bacterial-derived peptidoglycan was also 
compartmentalised with the AMCP nanomineral of Peyer’s patch APCs again in terms of 
inseparable fluorescent signals and also as separate but closely adjacent signals (Pearson 
correlation coefficient = 0.71) (Figure. 5l-o). 
Collectively the findings above pointed to role for endogenous gut nanomineral, which is 
functionally conserved in spite of dietary calcium and phosphate deficiency, in the selection 
and chaperoning of luminal macromolecules to Peyer’s patch APCs. Notably, these organic 
macromolecules, as well as the Mg ions of AMCP, may serve to stabilise the particle in its 
amorphous state for the lifetime of the nanomineral24,25. 
Finally, we considered how the process described above may contribute to normal intestinal 
homeostasis. 
Peptidoglycan potently stimulates the upregulation of the immunotolerance-associated co-
regulatory molecule PD-L1 (B7-H1/CD274) on the cell surface26. Whether this mechanism 
extends to the gut is unclear because APCs are conditioned locally and, at least in terms of pro-
inflammatory signalling, are refractory to stimulation by bacterial fragments27. We therefore 
investigated the PD-L1 status of AMCP+ cells of murine Peyer’s patches in both wild type mice 
and in NOD1 and NOD2 double knock out mice (NOD1/2−/−)28 which cannot recognise 
peptidoglycan. In wild type mice these cells were consistently PD-L1high (Fig. 6a and c). In 
contrast, in NOD1/2−/− mice, PD-L1 was undetectable on AMCP+ cells (Fig. 6b and d). In both 
wild type and NOD1/2−/− mice, sporadic low-moderate background PD-L1 expression was 
observed in the patch (Fig. 6a and b). This selective failure of PD-L1 expression in APCs of 
the intestinal nanomineral-antigen-peptidoglycan pathway indicates that peptidoglycan 
signalling must be intact to enable PD-L1 upregulation. 
Peptidoglycan signalling is required for PD-L1 expression on nanomineral-positive APCs 
of the Peyer’s patch sub-epithelial dome and mesenteric lymph nodes 
The intestinal immune response to orally-delivered protein involves cooperation between 
Peyer’s patches and mesenteric lymph nodes. In particular, migration of APCs to the 
mesenteric lymph nodes implies functional activity (i.e. antigen presentation) and we 
confirmed that mesenteric lymph nodes in wild type mice had significant numbers of AMCP 
nanomineral+ cells (Fig. 6e and g). These were PD-L1+, as in Peyer’s patches, while in the 
NOD1/2−/− mice PD-L1 was again absent (Fig. 6f and h). 
Collectively, these data suggest that in the absence of peptidoglycan recognition, antigen of the 
nanomineral pathway may be presented by APCs to T cells without the co-regulatory molecule 
PD-L1 and perhaps, therefore, without a tolerogenic instruction29. In this respect, it is 
interesting to note that in Crohn’s disease peptidoglycan recognition is known to be 
compromised in many patients, mostly due to mutations in NOD230, and that the earliest signs 
of disease appear to overlie lymphoid follicles such as Peyer’s patches31. Hence, whether this 
patient group represents the result of compromised PD-L1 expression in the nanomineral-
antigen-peptidoglycan pathway should now be investigated. 
Conclusions 
Peyer’s patch sampling of luminal contents, which will include some undigested dietary 
antigen, has long been recognised and is widely considered to be a form of local 
immunosensing and surveillance6. We now provide evidence that at least part of this process 
is mediated by an endogenous nanomineral chaperone, from lumen to APC, and that co-
delivery of peptidoglycan in this pathway conditions the APC phenotype by switching on PD-
L1. It is possible that MAMPs other than peptidoglycan are trapped and delivered to APCs in 
this fashion. However, at least for imprinting PD-L1 expression, they do not appear to signal 
as deficiency in NOD1 and NOD2, and hence peptidoglycan recognition, was sufficient to 
prevent PD-L1 expression in this pathway (Fig. 6). PD-L1 is immuno-inhibitory and is 
normally up-regulated during inflammation to help minimise tissue damage29. Failure to 
express PD-L1 in the intestine enhances the risk of inflammation32,33 but especially so when 
non-self antigen is being expressed34. Thus, not only might the nanomineral pathway ensure 
that luminal antigen and peptidoglycan reach sub-epithelial immune cells without enzymatic 
degradation en route but, additionally, it could ensure that the very cells in receipt of exogenous 
non-self antigens are also the ones expressing PD-L1. An acquired PD-L1high phenotype, in a 
minority of APCs that are selected to be in sync with the surveillance of soluble luminal 
contents, could ensure that tolerogenic signalling towards ‘harmless antigen’ is not overly 
dominant and, for example, that immune responsiveness towards invasive pathogens is 
maintained. Interestingly, the process adapts and remains fully functional under conditions of 
extreme dietary calcium and phosphate deficiency implying a degree of criticality in its 
function. 
Overall, we propose that our findings explain: (a) why the Peyer’s patch has such a remarkable 
ability for the uptake of non-biological nanoparticles in the ~20-250 nm range35,36; (b) how 
under constitutive conditions, luminal antigen and peptidoglycan can reach APCs of the 
Peyer’s patch sub-epithelial dome without prior enzymatic degradation; (c) how the commensal 
microbiota can influence local APC development and potentially calibrate susceptibility to 
inflammatory disease and (d) why endogenous calcium losses occur into the gut lumen37. Our 
data also provide evidence for constitutive and beneficial self-assembly (i.e. without an 
associated scaffold) of nanoparticles in humans yielding new insights into the interplay 
between nutrition, gut physiology and the mucosal immune system. Finally, Peyer’s patches 
are present at birth6 and mineralised calcium nano-structures probably exist in breast milk38-40. 
We speculate from the findings presented here that the nanomineral in breast milk may be more 
than an easily-absorbed form of calcium and facilitate early gut immuno-surveillance of 
maternal milk-borne antigens41. 
METHODS 
Tissue sampling 
Human samples were from St Thomas’ Hospital (London) with appropriate ethical approval. 
Fresh surgical human ileal tissue specimens (n=6 patients) were each about 20 mm by 20 mm 
in size. Samples were macroscopically normal and were the resection margins of tissue from 
patients undergoing surgery for Crohn’s disease (n=2), large bowel carcinoma (n=2) and non 
Crohn’s colitis (n=2). Luminal contents were provided from anonymised patients with 
ileostomies. Wild type (C57BL/6) murine ileal and large bowel tissues, as well as mesenteric 
lymph nodes, were obtained as surplus to requirement (LMB, Addenbrookes Hospital, 
Cambridge), or were from specific feeding studies8 (as decribed in the text) or were matched 
controls for murine models (all on C57BL/6 background) described below. All tissues or tissue 
contents were either (i) snap frozen in liquid nitrogen-cooled isopentane and then stored, 
unprocessed or in OCT freezing medium (Thermo Scientific, USA), in liquid nitrogen until 
further use or (ii) were processed and embedded in non-aqueous resin (Quetol651™-see 
below), as stated in the text. 
M cell deficient villin-cre+ RANKFL/FL mice 
Villin-cre+, but not villin-cre−, RANKFL/FL mice fail to express intestinal M cells as their 
differentiation is inhibited due to blockade of RANKL-RANK signalling11. Tissues from these 
mice, sustained on a normal laboratory chow diet, were studied. For whole-mount staining, 
Peyer’s patches were dissected and fixed with BD Cytofix/Cytoperm (BD Biosciences, Oxford, 
UK). For analysis of M cells in tissue sections, Peyer’s patches were removed and snap-frozen 
at the temperature of liquid nitrogen. Serial frozen sections (5 μm in thickness) or tissues were 
subsequently immunostained with rat anti-mouse GP2 mAb (MBL International, Woburn, 
MA). Following addition of primary Ab, tissues were stained with Alexa Fluor 488-conjugated 
anti-rat IgG Ab (Invitrogen, Paisley, UK) and counterstained with either Alexa Fluor 647-
conjugated phalloidin (Invitrogen) or DAPI. Sections were mounted in fluorescent mounting 
medium (Dako, Ely, UK) and examined using a Zeiss LSM710 confocal microscope (Zeiss, 
Welwyn Garden City, UK). Calcein staining and imaging was undertaken as below (staining 
and immunofluorescence) for regular wild type mice. For quantitation sections from the villin-
cre− (M cell normal) and villin-cre+ (M cell deficient) RANKFL/FL mice were sectioned, stained 
and imaged as blinded pairs to ensure precisely the same sample preparation and imaging 
parameters. Quantification of AMCP was carried out, on blinded sections, by manual selection 
(designation) of the sub epithelial dome area and then ImageJ open source software42 was used 
to acquire the percentage area of calcein staining. Differences in the percentage area of calcein 
staining between the villin-cre− and villin-cre+ mice were assessed by Mann-Whitney test. 
NOD1 and NOD2 double deficient mice 
NOD1/2 double knock out mice (NOD1/2−/−) were first generated and characterised in the 
group of Stephen Girardin (Toronto, Canada) and shipped to the Department of Pathology, 
Academic Medical Center, University of Amsterdam, for further study28. Peyer’s patches and 
mesenteric lymph nodes were freshly dissected from animals that were surplus to requirement 
and that had been sustained on a standard laboratory chow diet. Tissues were snap frozen and 
shipped to Cambridge (MRC HNR) for sample preparation and imaging. Calcein staining and 
imaging was undertaken as below (staining and immunofluorescence) for regular wild type 
mice: sections from NOD1/2−/− and wild type mice were sectioned, stained and imaged in pairs 
to ensure precisely the same sample preparation and imaging parameters. 
OVA feeding study and dietary mineral deprivation 
Adult female BALB/c mice, 6-8 weeks of age, were purchased from Harlan Olac (Bicester, 
U.K.) and kept under specific pathogen-free conditions. To determine co-localization of 
ovalbumin and endogenous nanominerals, mice received either 1 mg of Texas Red®-labelled 
or unlabelled ovalbumin (Invitrogen, Paisley, UK), as stated in the text, dissolved in 0.2 ml 
phosphate buffered saline by oral gavage using a stainless steel gavage needle. Four hours later 
small intestines were harvested for analysis. All experimental procedures were performed in 
accordance with the Home Office Animals Scientific Procedures Act (1986). Detailed 
information of diets is in Pele et al, 2007 (ref 8). Briefly, diets were formulated by Harlan-
Teklad and consisted of a baseline diet (the very low Ca diet) that had a natural molar 
calcium:phosphate ratio of 0.3:1. Increased Ca levels in the subsequent diets were through 
addition of dibasic calcium phosphate (CaHPO4.2H2O) and calcium carbonate (CaCO3) to 
achieve a calcium:phosphate ratio of 1.3:1 (i.e. normal ratios of these elements in a standard 
rodent non-purified diet). Final Ca levels of the diets were 0.009% for the very low, 0.05% for 
the low, 0.5% for the normal, and 1.5% for the high Ca diets. 
Scanning electron microscopy (SEM) and elemental analysis of tissue samples 
Tissue samples were cryo-sectioned on a Leica CM30505 cryostat, set at −24 °C, with a section 
thickness of ~10 μm. Resulting sections were air dried on to Melinex films and subsequently 
attached to SEM stubs with silver dags (Agar, UK). They were carbon-coated before being 
placed in the SEM chamber for analysis. The samples were imaged with a Philips/FEI XL30 
field emission gun (FEG) SEM using secondary or back scattered electron detectors as noted 
in the text. Energy Dispersive X-ray Spectroscopy (X-ray microanalysis) was carried out at 20 
kV using an Oxford Instruments ATW SiLi spectrometer running their INCA software. 
Transmission electron microscopy and elemental analysis 
Human and murine samples were fixed in 2% acrolein in polypropylene glycol, dehydrated in 
ethanol and embedded in ‘Quetol 651’ epoxy resin. The resin was cured at 60 °C and sections 
were cut to 70 nm thicknesses before mounting on TEM grids. To allow the endogenous 
nanomineral to be easily visualised in a tissue background we avoided the use of heavy-metal 
contrast agents (e.g. uranyl acetate and lead citrate) leaving sections unstained. Sections were 
examined in a FEI CM200 FEG-TEM operating at 200 kV and fitted with an Oxford 
Instruments ultra-thin window energy dispersive X-ray (EDX) spectrometer and a Gatan 
imaging filter (GIF 200). We imaged at magnifications that would readily allow particles > 20 
nm in diameter to be observed. The elemental content of visualised particles was measured in 
the TEM by focussed probe-EDX spectroscopy. Ca/P or [Ca(+Mg)]/P ratios were determined 
from the Oxford Instruments ISIS processing software using virtual standards for the Mg, Ca 
and P Kα X-ray peaks, monitored at a take-off angle of 20° and a specimen tilt angle of 15°. 
Care was taken to minimise the intensity of the incident electron beam because calcium 
phosphate particles are susceptible to irradiation damage by the high energy electrons; this 
results in significant mass loss for materials such as hydroxyapatite which can decompose to 
calcium oxide following prolonged exposure43,44. Selected area electron diffraction (SAED) 
was conducted using a selected area aperture of approximately 0.18 μm diameter in the image 
plane. 
Scanning transmission electron microscopy and 3 dimensional tomography 
Murine samples were fixed and embedded as above. Tomography experiments based on high-
angle annular dark-field (HAADF) imaging in the scanning transmission electron microscopy 
(STEM) mode were performed at 200 kV on a FEI Tecnai F20 FEG-TEM tilting the sample 
from −42° to +70° at 2° intervals about a single axis using a Fischione 2020 ultra-high-tilt 
tomography holder. Using the Inspect 3D software, tilt series were aligned by cross-correlation 
and reconstructed using the SIRT algorithm (with 20 iterations). 
Nuclear microscopy 
Particle-induced X ray emission was carried out as previously described2 using the microbeam 
facility of the Surrey Ion Beam Centre, Guildford UK [www.ionbeamcentre.co.uk]. The 
samples were mounted in the sample chamber of the nuclear microprobe at the University of 
Surrey Ion Beam Centre and were scanned using a beam of 3 MeV protons from a 2 MV 
Tandetron accelerator focused to a diameter of 1–2 μm. The average beam current varied 
between 100 pA and 200 pA. Induced X-rays were detected using a lithium-drifted silicon 
detector at a variable distance of 20–50 mm from the sample (Gresham Scientific Ltd., 80 mm2 
active area). Based upon parallel confocal microscopy observations, elemental maps ranging 
from 1 × 1 mm2 to 100 ×100 μm2, were recorded. PIXE spectra from individual particles were 
recorded by positioning the beam on each particle area sequentially. Unpaired, 2-tailed student 
t tests were applied to assess differences between low Ca/P and high Ca/P diets. 
Confocal microscopy 
Work with traditional paraffin-embedded specimens indicated that endogenous nanominerals 
were lost and/or artefactually mobilised during processing and so all confocal microscopy was 
carried out on frozen sections. Peyer’s patches were cryo-sectioned (Leica CM3050S) at 12 
μm and collected on SuperFrost® slides (Thermo Scientific, USA) and allowed to air dry for 
30 min at room temperature. Unless otherwise stated, sections were imaged with a Leica SP2 
confocal microscope (Leica Microsystems, Germany) at 488, 568 or 633 nm laser lines, fitted 
with diode Ar/ArKr and HeNe lasers, using either a ×25 multi-immersion lens or a ×63, 1.2 
NA water objective lens. Data were recorded using the Leica Confocal Software (v2.61) and 
images processed using the open-source ImageJ software42. Data were collected as 8-bit 
greyscale images and assigned appropriate colours subsequently: nuclei are shown grey or blue 
to best facilitate visualisation of the non-nuclear stains (i.e. calcein and fluorescent antibodies 
against ovalbumin, peptidoglycan and cell surface markers). 
Staining and Immunofluorescence 
Staining for endogenous nanomineral  
Modified Von Kossa Staining: Sections were fixed in 10% w/v formaldehyde-PBS (Sigma) for 
10 min followed by immediate washing in ultra high purity (UHP) water for 5 min. The washed 
sections were placed in a Coplin jar containing 1% silver nitrate solution and incubated for 1 h 
at room temperature, then washed in UHP water for 5 min. The sections were covered with 
UHP water and incubated under ultraviolet light for 1h, followed by a dip in 5% sodium 
thiosulphate solution for 5 min to remove the un-reacted silver. After a final wash in UHP water 
for 5 min, sections were counter stained with haematoxylin solution for 1 min, washed and 
dehydrated using three changes of IMS and cleared with three changes of xylene. The sections 
were coversliped using xylene based DPX. 
Calcein staining: Sections were fixed in 2% formaldehyde-PBS (Sigma) for 10 min and then 
washed in three changes of 0.1 M Tris-HCL buffer, for 3 min each. Fixed sections were 
incubated with 2.5 μM calcein Tris-HCL solution in a glass coplin jar for 20 min at room 
temperature and with light exposure restricted to the minimum. Following incubation, the 
sections were washed carefully with three changes of 0.1 M Tris-HCl buffer for 3 min each. 
Double staining for endogenous nanomineral and phenotypic markers  
Murine sections were fixed using 4% (w/v) formaldehyde-PBS (Sigma) for 10 min and then 
washed with 3 changes of Tris-buffered saline (TBS) at pH 8.2. Sections were then blocked for 
2 h using 5% goat serum (PAA Laboratories, UK), 1% bovine serum albumin (Sigma), 0.3 M 
glycine (Sigma) and 0.1% Triton X-100 (Sigma) in TBS and washed with 3 changes of TBS. 
Primary antibodies for CD11c and CD11b were next applied and incubated for 1 h and 4 h 
respectively. Following washing with 3 changes of TBS, sections were then incubated with 
secondary antibodies, for 1 h, and finally washed with 3 changes of TBS. Primary antibodies 
were Rat anti-mouse CD11b (M1/70) (Biolegend, USA) at 1:200 working concentration and 
Hamster anti-mouse CD11c (N418) (AbD Serotec, UK) at 1:100 working concentration. 
Secondary antibodies were Goat anti-rat IgG (H+L) Alexa Fluor® 568 (Invitrogen, UK) at 
1:200 working concentration and Goat anti-hamster IgG (H+L) Alexa Fluor® 568 (Invitrogen, 
UK) at working concentration 1:200. 
Human sections were fixed in 2% formaldehyde (4 °C, 10 min), washed with 0.1 M Tris buffer 
(pH 8.0) and incubated with primary antibodies for CD68, HLA-DR and CD14 for 1 h at room 
temperature (RT), and for CD11b and CD11c overnight at 4°C. After further washing in 0.1 M 
Tris buffer, the slides were then incubated with biotinylated secondary antibodies (diluted in 
foetal calf serum 1:250, v/v) for 1 h at RT and labelled with Alexa Fluor® 568 conjugated 
streptavidin to enable detection (1 h, RT). All sections (i.e. murine and human) were finally 
stained with calcein for endogenous nanomineral and counterstained with To-Pro 3 (Invitrogen, 
UK) or propidium iodide respectively. Sections were washed with three changes of TBS and 
permanently mounted with ProLong® gold antifade reagent (Invitrogen, UK). These cell 
surface antigens were all confirmed in specific, positive-control tissues that contain cells 
expressing these markers (namely appendix, placenta and tonsil). 
Double staining for endogenous nanomineral and PD-L1  
Murine sections were fixed using 4% (w/v) formaldehyde-PBS (Sigma) for 10 min and then 
washed with 3 changes of Tris-buffered saline (TBS) at pH 8.2. Sections were then blocked for 
1 h using 10% goat serum (PAA Laboratories, UK), 1% bovine serum albumin (Sigma), 0.3 M 
glycine (Sigma) and 0.1% Triton X-100 (Sigma) in TBS and washed with 3 changes of TBS. 
The primary antibody for PD-L1 (10F.9G2) (Biolegend, USA) was next applied and incubated 
for 1 h. Following washing with 3 changes of TBS, sections were then incubated with Goat 
anti-rat IgG (H+L) Alexa Fluor® 568 (Invitrogen, UK) at 1:200 working concentration, for 1 
h, and finally washed with 3 changes of TBS. 
Staining for endogenous nanomineral and dietary antigen, bacterial peptidoglycan and 
lysozyme  
Dual staining for the dietary protein ovalbumin and for endogenous nanomineral was achieved 
using OVA-Alex Fluor® 633 and calcein, respectively, and as described above for murine 
sections. Staining for bacterial peptidoglycan was achieved by using the mouse Mab 2E9 
(mouse IgG3)23. Briefly, human sections were fixed in 2% formaldehyde (4 °C, 10 min). After 
three washes in Tris buffer (pH 7.4), sections were blocked in 1% BSA/Tris buffer and then 
incubated with biotinylated 2E9 (diluted 1:500 in Tris buffer) overnight, at 4°C. After further 
washing, sections were subsequently incubated with streptavidin (1:100, 30 min, RT) and with 
TSA (1:100, 10 min, RT). Endogenous nanomineral staining and nuclear counterstain were 
finally carried out as described above for sections of human tissue. 
Lysosomal staining was by anti-lysozyme antibody. Sections of human Peyer’s patch were 
fixed in 4% PFA (10 minutes), blocked with normal serum (5% goat serum, 1% BSA in PBS 
at pH 7.8 for 1 hour at room temperature) and incubated with mouse anti-lysozyme (Clone: 
[BGN/06/961]; Abcam, UK) at 1:50 dilution and 4 °C overnight. The primary antibody was 
detected using goat anti-mouse Alexa Fluor® 568 antibody (1:200 1 hour, room temperature; 
Invitrogen, UK). AMCP nanomineral was stained with calcein (0.001M, 30 minutes, room 
temperature; Sigma, UK) and the nuclei stained with Hoescht 33342 (2 μg/ml, 20 minutes, 
room temperature). 
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